Reach the 3 Million Find, Treat, Cure TB BASIC CONTENTS OF RNTCP WEBSITE OF THE DIRECTORATE OF HEALTH SERVICES, ODISHA

Size: px
Start display at page:

Download "Reach the 3 Million Find, Treat, Cure TB BASIC CONTENTS OF RNTCP WEBSITE OF THE DIRECTORATE OF HEALTH SERVICES, ODISHA"

Transcription

1 BASIC CONTENTS OF RNTCP WEBSITE OF THE DIRECTORATE OF HEALTH SERVICES, ODISHA About us The National Tuberculosis Control Programme (NTP) was implemented in Orissa in the year 1964 with the objective to provide free and domiciliary treatment to the patients detected through passive case finding method. The NTP did not achieve the desired success as a result the programme was revised with the DOTS (Directly Observed Treatment Short Course Chemotherapy) strategy and implemented in our State in the year 1997 with the objective to detect 70% of infectious sputum positive TB cases and cure at least 85% of them. The programme is implemented as per the Technical, Operational and Financial guidelines of Revised National TB Control Programme (RNTCP). The RNTCP was assisted by Danida through Government of India from 1996 to The Global Fund to fight AIDS, TB and Malaria (GFATM) provides financial and technical support to implement the programme in the State from the year 2006 to 2010 through Government of India. The Rolling Continuation Channel (RCC) project of GFATM has been extended till the year The Government of India releases necessary funds to the Director of Health Services, Orissa through the Orissa State Health & Family Welfare Society on the basis of the Statement of Expenditure, Audit report and Annual Action Plan. Govt. of India also provides 100% requirement of anti TB drugs for treatment under RNTCP. The Lepra-India, an international NGO, is also providing support under Axshaya project to IEC-BCC activities in 12 districts of Orissa (Angul, Bhubaneswar, Cuttack, Gajapati, Ganjam, Koraput, Kandhamal, Malkangiri, Mayurbhanj, Puri, Sambalpur and Sundargarh) The Catholic Bishop Conference of India (CBCI) and the Indian Medical Association (IMA) are also involved in RNTCP of the State. Organogram: State TB Officer at Health Directorate, Odisha. District TB Officer at all District Head Quarters & Capital Hospital, Bhubaneswar. Designated Medical Officer at Sub-district (Block level) TB Unit (MO-TU) Medical Officer at Designated Microscopy Centre DOTS Centre

2 Activity Sr. No. RNTCP Performance of Odisha State at a glance (Key indicators) 2014 (Jan - Dec 2014) Indicator Norm Achievement % 1 Population covered (in lacs) % of PHIs referring more than 2% of new Adult OPD for sputum examination 1,976 37% 3 TB Suspects examined per lac population/qtr > Sputum Smear Positive Patients diagnosed 8-12 % 27,966 12% Sputum Smear Positive Patients living in the district and put on DOTS New Sputum Smear Positive Patients put on treatment Annualised New Sputum Smear Positive detection rate per Lac > 95% 23,383 91% >60 /lac/yr and >70% 20, % 8 Total TB Cases put on treatment 9 Annualised Total Case Detection Rate per Lac 230 / lac 45, % of new EP cases out of all new cases 10-15% 24% % of retreatment cases out of all smear positive cases % of new smear positive out of total new pulmonary cases 3 Months Sputum Conversion of New Smear Positive cases registered in the last Quarter Cure Rate of New Sputum Positive Cases registered in corresponding quarter of last year Success Rate of New Sputum Positive Patients registered in corresponding quarter of last year 20-40% 16% 45-70% >90% out of out of % 88% out of >85% % out of >85% %

3 Contacts IMPORTANT CONTACT NUMBERS - RNTCP - ODISHA Sl. No Name Designation ID Mobile Office Dr. (Mrs) Sanjukta Sahoo Dr. Sachidananda Mishra Dr. P.G. DasMahapatra Joint Director TB-cum-STO stoor@rntcp.org Asst. Program Officer cum Epidemiologist stoor@rntcp.org TB HIV Coordinator stoor@rntcp.org MO, State TB Dr. Laxmidhar Pradhan Cell stoor@rntcp.org Phone Name of ATD&TC Officials Designation ID Mobile (Office) Superintendent Dr. Sanjit Pattanaik ATD&TC stdcor@rntcp.org Dr. Gautam Patnaik MO ATD&TC stdcor@rntcp.org Dr. Paresh Nath Mohanty Microbiologist, stdcor@rntcp.org; ATD&TC pareshmohanty67@gmail.com Phone Name of WHO Consultant Region ID Mobile (Office) Dr. Sandeep Kindo Dr. Rajendra Narayan Panigrahi Dr. Balakrishna Panda Western Odisha KindoS@rntcp.org HQ, Odisha PanigrahiR@rntcp.org Southern Odisha pandab@rntcp.org

4 Programmes / Schemes Reach the 3 Million Present Status Since inception of RNTCP in 1997 till 2014, total 6,03,103 TB cases have been detected and treated. Total 4,71,687 cases have been cured & successfully completed treatment and 28,062 cases reported died. Out of the said reported death cases all deaths may not be due to TB. It includes death due to other causes also. In the year 2014, the annualized new sputum positive case detection rate of Orissa was 55% against the norm of 70% and the success rate 86% as against the norm of 85%. The programme is implemented though 31 implementing units, 159 TB Units and 549 Microscopy centers. 48,993 DOT Centres are functioning under the programme to provide DOTS to the registered TB patients. The programme has the following major activities. o DOTS for CAT-I & CAT-II patients o PMDT (Programmatic Management of Drug Resistant TB) for CAT-IV & CAT-V patients (for MDR & XDR TB patients respectively) o Intensified TB-HIV activities to ensure 100% testing for HIV of all diagnosed TB cases & treatment of co-infected patients. o Entry of data in NIKSHAY portal of RNTCP of all diagnosed TB patients. o Notification of all diagnosed and treated TB patients is mandatory for all Laboratories, Private Practitioner and Hospitals. o Medical college involvement Presently 6 out of 7 including AIIMS Bhubaneswar are involved in the program for diagnosis and treatment of TB patients in the Medical colleges The Anti TB Demonstration & Training Centre (ATD&TC) Cuttack is functioning as a training center of RNTCP and conducts External Quality Assessment (EQA) to maintain good quality sputum microscopy. Intermediate Reference laboratory (IRL) at Anti TB Demonstration & Training Centre, Cuttack accredited on 10th Aug 2009 conducting solid culture, Liquid Culture for Culture & DST of M Tb & Line Probe Assay (LPA). It is matter of pride for the State that Regional Medical Research Centre, Bhubaneswar has been declared as a new National Reference laboratory for the Eastern and North Eastern region of India. It has been accredited for culture and Drug Susceptibility Test for solid culture, supporting for follow up cultures from 7 districts (Koraput, Nabarangpur, Kalahandi, Rayagada, Gajapati, Kandhamal & Malkangiri). NRL RMRC Bhubaneswar is also supporting Diagnostic samples of MDR suspects from districts of Nabarangapur, Kalahandi, Rayagada, Gajapati, Malakngiri. PMDT (Programmatic Management of Drug Resistant TB Cases) rolled out in the entire state. Till 3Q14, out of the sputum samples of 5499 Drug Resistant TB (DR-TB) suspects examined, 700 patients have been diagnosed as Drug Registrant TB and out of them 613 patients (88%) have been initiated on treatment since the year 2009 till In addition 21 nos. of XDR TB patients have been detected under RNTCP. All drugs and diagnostics are provided free of cost.

5 Reach the 3 Million Diagnosed DR-TB patients can now be admitted in the existing DR TB wards at SCB, VSS & MKCG Medical College. TB and HIV collaborative services have been strengthened in all districts with the state progressively increasing the proportion of TB patients tested for HIV. The TB HIV Intensive Package is implemented in all the districts since 2010 in collaboration with the OSACS. During the year 2014 out of total registered TB patients, (68.4%) are examined and 628 found TB-HIV co-infected. To further improve TB surveillance in both Private and Public sectors in India, NIKSHAY a real time, online notification, recording and reporting system has been implemented in the state with most of the districts entering data for all the patients registered in Till date 72,541 patients from Govt. Sector have been entered in the Nikshay portal. Block level MIS-Coordinators along with STS play an important role to ensure 100% entry in this portal. TB Notification which has been made mandatory as per GoI notification has been initiated and reporting of TB patients from private Sector started. Our partner Indian Medical Association (IMA), Odisha is fully supporting our efforts. Till date (4Q14) 1111 TB patients had been notified and registered from Private sector in NIKSHAY. The State Task Force (STF) mechanism for the involvement of all Medical Colleges in RNTCP is operational, headed by DMET as STF Chairperson. As such three Govt Medical Colleges of our State and SUM Medical College & Hospital Bhubaneswar have received one LED Microscope each for diagnosis of TB cases. The State has organized National Task Force (NTF) Workshop in the month of March 2014 and Zonal Task Force (ZTF) meeting on January 2015 in Bhubaneswar for active involvement of Medical colleges in RNTCP. State has optimally rolled out Tribal action plan in 11 notified tribal districts catering to 22.47% of tribal population of the State. To further improve TB surveillance in both Private and Public sectors in India, Nikshay a real time, online notification, recording and reporting system has been implemented in the state with most of the districts entering data for all the patients registered in Till date 72,541 patients from Govt. Sector have been entered in the Nikshay portal. School awareness programmes, Patient Provider interaction meeting, PRI Sensitization, Street Play & Folk Dance are conducted at district level to create awareness for early diagnosis and treatment of TB. In addition Swasthya Kantha in all villages is being utilized to disseminate TB messages to the community The programme is also supported by Partners like Axshaya GF-TB Project in 12 districts, Indian Medical Association and Catholic Bishop Conference of India (CBCI) and Red Cross India.

6 Notifications TB has been declared a notifiable disease by the Govt of India and subsequently by the Govt. of Odisha on Advertisements To be updated whenever there is an advertisement. RTI Act Link For any information regarding TB and its control including recent developments in the filed of diagnosis & treatment and achievements of different States etc, the National website of RNTCP can be accessed at News & Updates World TB Day is observed on 24 th March every year to commemorate discovery of TB bacillus by Robert Koch, a German Scientist, in the year This discovery led to inventions of appropriate medications to fight TB. Indian Medical Association (IMA) has made TB notification mandatory and published the said notification in a separate Resolution. The 4 th DR TB Centre has been established at DHH Koraput to diagnose DR TB using CBNAAT (Cartridge Based Nucleic Acid Amplification Test) technique. Archive Section - With administration of DOTS a TB patient has been cured and could be able to lead a happy life and earn his livelihood.

7 - Poster to use DOTS more widely: Reach the 3 Million

8 - Declaration of IMA regarding mandatory notification of TB:

9 - Declaration of Govt. of Odisha regarding notification of TB on :

10 - Govt. of India ban on use of Serodiagnostic kit to diagnose TB:

11 Photo Gallery (RNTCP reviewed by the Secretry Health & FW Odisha) (ASHAs of Baliguda Sub Divison Promising for their active Involvment in TB Case Detection and Cure) (Children Participation in TB Awareness) (TB Awareness Rath) Download Forms (Administering DOTS by ASHA) All forms, modules of RNTCP can be downloaded from the National website

Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor

Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Global scenario*: Burden of TB Incidence : 9.6 million (58% SEAR and Western Pacific) Deaths : 1.5 million

More information

Malaria: Bringing Down The Burden In Odisha. Dr. MM Pradhan Dy. Director, NVBDCP, Odisha

Malaria: Bringing Down The Burden In Odisha. Dr. MM Pradhan Dy. Director, NVBDCP, Odisha Malaria: Bringing Down The Burden In Odisha Dr. MM Pradhan Dy. Director, NVBDCP, Odisha MMV Stakeholders Meeting, Delhi (India), 8 th Nov, 212 Odisha at a glance Area: 156, sq kms (4% of India s land area)

More information

India s Contribution in Rolling out Newer and Rapid Diagnostics towards PMDT Scale-up

India s Contribution in Rolling out Newer and Rapid Diagnostics towards PMDT Scale-up India s Contribution in Rolling out Newer and Rapid Diagnostics towards PMDT Scale-up Balasangameshwara Vollepore, FIND (India) FIND and Partners Symposium 43 rd Union World Conference on Lung Health November

More information

Revised National Tuberculosis Control Programme

Revised National Tuberculosis Control Programme Revised National Tuberculosis Control Programme 1 OUTLINE OF PRESENTATION Introduction Burden Of The Disease Evolution Of RNTCP Goals And Objectives Of RNTCP DOTS Stop TB Strategy Organization RNTCP Endorsed

More information

Role of RNTCP in the management MDR-TB

Role of RNTCP in the management MDR-TB Kamdar DJ, Shah NA, Patel DJ, Parmarr H. Role of RNTCP in the management of MDR-TB. IAIM, 2015; 2(7): 1-5. Original Research Article Role of RNTCP in the management of MDR-TB Deepali J Kamdar 1, Neha A

More information

Concern India HIV Programme

Concern India HIV Programme Concern India HIV Programme Background Orissa HIV Scenario HIV prevalence in general population is 0.22% Ganjam is the 2 nd high prevalent district in India (prevalence rate is 3.25%) 16,733 persons identified

More information

PROJECT AXSHYA COMMUNITY ENGAGEMENT in TB CARE

PROJECT AXSHYA COMMUNITY ENGAGEMENT in TB CARE PROJECT AXSHYA COMMUNITY ENGAGEMENT in TB CARE An NGO-consortium initiative by World Vision India & Partners 4 th Dec 15 CSOs TB Project supported by The GFATM Round 9 grant PR: World Vision India SRs:

More information

Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes

Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes Dr Amal Bassili Stop TB unit, WHO, Regional Office for the Eastern Mediterranean Surveillance

More information

TUBERCULOSIS CONTROL SAARC REGION

TUBERCULOSIS CONTROL SAARC REGION TUBERCULOSIS CONTROL SAARC REGION UPDATE 2009 SAARC Tuberculosis & HIV/AIDS Centre (STAC) (Thimi, Bhaktapur), P. O. Box No. 9517, Kathmandu, Nepal. Tel: 6631048, 6632477, 6632601 Fax: 00977-1-6634379 E-mail:

More information

Performance of RNTCP NTI Bulletin 2005,41/3&4,

Performance of RNTCP NTI Bulletin 2005,41/3&4, Performance of RNTCP NTI Bulletin 2005,41/3&4, 118-122 A Cohort Analysis of Performance of RNTCP in MS Subramanya Rao*, KP Unnikrishnan**, MA Sharada BACKGROUND Tuberculosis (TB) is one of the most serious

More information

GENDER DISPARITY ODISHA, Directorate of Economics and Statistics, Odisha, Bhubaneswar

GENDER DISPARITY ODISHA, Directorate of Economics and Statistics, Odisha, Bhubaneswar GENDER DISPARITY ODISHA, 2010 Directorate of Economics and Statistics, Odisha, Bhubaneswar 4 GENDER DISPARITY ODISHA, 2010 Directorate of Economics and Statistics, Odisha, Bhubaneswar 5 Shri Panchanan

More information

Tuberculosis Screening and IPT: Experience from India

Tuberculosis Screening and IPT: Experience from India Tuberculosis Screening and IPT: Experience from India Dr B.B.Rewari WHO National consultant Care, Support and Treatment National Programme Officer (ART) National AIDS Control Organization New Delhi-110001,

More information

Overview of the Presentation

Overview of the Presentation Overview of the Presentation Definitions(TBCase, MDR-TB & XDR-TB) Global Tuberculosis (TB,HIV/TB,MDR & XDR)Scenario & Trend Risk factor for TB Natural history of TB Types of TB & Trends of Extra Pulmonary

More information

Tuberculosis in the SAARC Region An Update 2007

Tuberculosis in the SAARC Region An Update 2007 SAARC Tuberculosis and HIV/AIDS Centre Tuberculosis in the SAARC Region An Update 27 SAARC Tuberculosis and HIV/AIDS Centre (STC) (Thimi, Bhaktapur) P. O. Box No. 9517, Kathmandu, Nepal Tel: 977-1-663148,

More information

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance

More information

COMMONEST CAUSE OF INITIATING CATEGORY II DIRECTLY OBSERVED TREATMENT SHORT COURSE IN TUBERCULOSIS PATIENTS

COMMONEST CAUSE OF INITIATING CATEGORY II DIRECTLY OBSERVED TREATMENT SHORT COURSE IN TUBERCULOSIS PATIENTS Original Research Article DOI - 10.26479/2016.0204.06 COMMONEST CAUSE OF INITIATING CATEGORY II DIRECTLY OBSERVED TREATMENT SHORT COURSE IN TUBERCULOSIS PATIENTS Manthan Mehta 1, Cherylann Melo 2, Shital

More information

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB Global Consultation Geneva, 30 November 2010 Mario C. Raviglione, M.D. Director, Stop TB Department WHO, Geneva,

More information

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director. 30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE

More information

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5%

More information

TB Program and Epidemic aka B2B

TB Program and Epidemic aka B2B TB Program and Epidemic aka B2B Nulda Beyers On behalf of DTTC BOD Workshop 30 September2013 Trend in tuberculosis incidence, selected countries in Africa 1400 1200 Rate per 100,000 1000 800 600 400 200

More information

Tuberculosis-HIV epidemic situation and emerging challenges in North India

Tuberculosis-HIV epidemic situation and emerging challenges in North India NTI Bulletin 2015,51 /1&4, 1 7 Tuberculosis-HIV epidemic situation and emerging challenges in North India Rajesh Deshmukh 1,3, Raghu Ram Rao 2, Shah A 2,3, Sreenivas A Nair 3, R S Gupta 1, SD Khaparde

More information

Revised National Tuberculosis Control Programme

Revised National Tuberculosis Control Programme Revised National Tuberculosis Control Programme 2015 C e n t r a l T B D i v i s i o n D i r e c t o r a t e G e n e r a l o f H e a l t h S e r v i c e s M i n i s t r y o f H e a l t h & F a m i l y

More information

USAID TB CARE II Bangladesh:

USAID TB CARE II Bangladesh: B ANGLADESH USAID TB CARE II Bangladesh: Grants Spotlight This document has been developed by the TB CARE II project and is made possible by the generous support of the American people through the United

More information

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each

More information

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 Definitions and reporting framework for tuberculosis 2013 revision Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 2-year revision process WHO/HTM/TB/2013.2 2 www.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf

More information

WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010

WHO Task Force Framework on assessment of TB surveillance data - Revisiting the Onion model Ana Bierrenbach WHO consultant Nov/Dec 2010 WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010 Task Force on TB Impact Measurement Mandate To produce a robust,

More information

Delivering Integrated HIV/TB Services in India: Challenges and Opportunities in National AIDS Control Program (NACP) IV.

Delivering Integrated HIV/TB Services in India: Challenges and Opportunities in National AIDS Control Program (NACP) IV. Delivering Integrated HIV/TB Services in India: Challenges and Opportunities in National AIDS Control Program (NACP) IV. Introduction: Deshmukh Rajesh 1 Ashok Kumar 1 K.S.Sachdeva 2 Amar Shah 2 India is

More information

DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION

DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION JOURNAL OF PREVENTIVE MEDICINE 2008; 16(3-4): 3-9 Inviting Editorial DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION Harshad Thakur Centre for Health Policy, Planning and Management,

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Short Communication First Line Drug Resistance Study in Pulmonary Tuberculosis Patients from Prakasini Satapathy 1, Bairagi

More information

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words

More information

Challenges in Scaling-up TB/HIV collaborative activities in a diverse HIV epidemic -India

Challenges in Scaling-up TB/HIV collaborative activities in a diverse HIV epidemic -India Challenges in Scaling-up TB/HIV collaborative activities in a diverse HIV epidemic -India Dr. B. B. Rewari WHO National Consultant National Programme Officer (ART) National AIDS Control Organisation New

More information

Rev Re ised Na tional TB Con Con ro r l Pr ogr ogr mme T chnic chnic l a & Oper Oper t a ional Guideline for TB Control in India March 2016

Rev Re ised Na tional TB Con Con ro r l Pr ogr ogr mme T chnic chnic l a & Oper Oper t a ional Guideline for TB Control in India March 2016 Revised National TB Control Programme Technical & Operational Guideline for TB Control in India March 2016 Why TOG and why it is required? October 2005 As per the programme developments, time to time it

More information

Xpert MTB/RIF assay validation experience --- impact and plan in China

Xpert MTB/RIF assay validation experience --- impact and plan in China Xpert MTB/RIF assay validation experience --- impact and plan in China Dr. Zhao Yanlin Chinese Center for Disease Control & Prevention Dr. Richard O Brien FIND April. 16, 2013 Progress Contribution for

More information

WR s Speech on inaugural ceremony of Community based Programmatic Management of Drug resistance TB (CPMDT).

WR s Speech on inaugural ceremony of Community based Programmatic Management of Drug resistance TB (CPMDT). WR s Speech on inaugural ceremony of Community based Programmatic Management of Drug resistance TB (CPMDT). The Chief guest Prof. Dr. A.F.M. Ruhul Haque M.P Hon ble Minister, Ministry of Health and Family

More information

Tuberculosis Control In The South-East Asia Region: Annual TB Report 2015 By WHO Regional Office for South-East Asia READ ONLINE

Tuberculosis Control In The South-East Asia Region: Annual TB Report 2015 By WHO Regional Office for South-East Asia READ ONLINE Tuberculosis Control In The South-East Asia Region: Annual TB Report 2015 By WHO Regional Office for South-East Asia READ ONLINE If you are searched for the ebook Tuberculosis Control in the South-East

More information

IMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE

IMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE Original Article IMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE P. G. Gopi, R. Subramani, V. Chandrasekaran, T. Santha and P. R. Narayanan

More information

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative

More information

The predominance of female deficiency has been a

The predominance of female deficiency has been a a case study International Journal of Commerce and Business Management ; Vol. 4 Issue 1 (April, 2011) : 155-162 A critical analysis of sex ratio in n scenario with special reference to Orissa Received

More information

Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan

Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan 2006-2015 Background Current threat and status of the global epidemic of multidrug resistant tuberculosis (MDR-TB) Along with HIV/AIDS, MDR-TB

More information

Treatment Outcome of Pulmonary and Extra Pulmonary Tuberculosis Patients in TB and Chest Disease Hospital DOT Centre, Goa, India

Treatment Outcome of Pulmonary and Extra Pulmonary Tuberculosis Patients in TB and Chest Disease Hospital DOT Centre, Goa, India International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 4 (2016) pp. 437-441 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.504.051

More information

TOG The Way Forward

TOG The Way Forward TOG 2016- The Way Forward Main Changes in Diagnostic algorithm Definition (Type, Classification, Outcome) Registration at the time of Diagnosis (PHI level Notification Register) Long term follow up (till

More information

The Three I s for HIV/TB and Rolling out IPT beyond Pilot -India

The Three I s for HIV/TB and Rolling out IPT beyond Pilot -India The Three I s for HIV/TB and Rolling out IPT beyond Pilot -India Dr. B. B. Rewari WHO National Consultant National Programme Officer (ART) National AIDS Control Organisation New Delhi, India 1 Content

More information

STATUS OF RE-REGISTERED PATIENTS FOR TUBERCULOSIS TREATMENT UNDER DOTS PROGRAMME

STATUS OF RE-REGISTERED PATIENTS FOR TUBERCULOSIS TREATMENT UNDER DOTS PROGRAMME Original Article STATUS OF RE-REGISTERED PATIENTS FOR TUBERCULOSIS TREATMENT UNDER DOTS PROGRAMME V.Chandrasekaran, P.G.Gopi, T.Santha, R.Subramani and P.R.Narayanan (Original received on 24.4.2006. Revised

More information

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition

More information

Experience with implementation of Xpert MTB/RIF in India. Dr K S Sachdeva Addl. DDG (TB), Government of India

Experience with implementation of Xpert MTB/RIF in India. Dr K S Sachdeva Addl. DDG (TB), Government of India Experience with implementation of Xpert MTB/RIF in India Dr K S Sachdeva Addl. DDG (TB), Government of India Background Two ongoing projects being implemented in India, under RNTCP by FIND Gene Xpert feasibility

More information

Investing for Impact

Investing for Impact Global Fund Strategic Framework: Investing for Impact M&E: Capturing data to improve services Workshop to Scale Up the Implementation of Collaborative TB/HIV Activities in Africa 10-11 April, 2013; Maputo,

More information

National framework for joint. TB-Diabetes. collaborative activities. Revised National Tuberculosis Control Programme (RNTCP)

National framework for joint. TB-Diabetes. collaborative activities. Revised National Tuberculosis Control Programme (RNTCP) National framework for joint TB-Diabetes collaborative activities Revised National Tuberculosis Control Programme (RNTCP) National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular

More information

POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH

POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH Akos Somoskövi, M.D., Ph.D. and Giorgio Roscigno, M.D. ANNUAL GLI MEETING, 4 th OCTOBER 2010 MERIEUX FOUNDATION, ANNECY Integrated Laboratory Network

More information

Briefing on Intensified Malaria Control Project-3 (IMCP-3)

Briefing on Intensified Malaria Control Project-3 (IMCP-3) Briefing on Intensified Malaria Control Project-3 (IMCP-3) India CCM Induction and Orientation Workshop 3 rd -4 th December 2015 Directorate of National Vector Borne Diseases Control Programme, Delhi Plan

More information

Let s Talk TB. A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Let s Talk TB. A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Lancelot M. Pinto, MD, MSc Author Madhukar Pai, MD, PhD co-author and Series Editor Abstract Nearly 50% of patients with

More information

National TB Prevalence survey in Myanmar. By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health

National TB Prevalence survey in Myanmar. By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health National TB Prevalence survey in Myanmar By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health 58 million pop. 676,577 sq km (75/sq km) S+ notification rate/100,000 population

More information

How best to structure a laboratory network with new technologies

How best to structure a laboratory network with new technologies How best to structure a laboratory network with new technologies Cristina Gutierrez, MD, PhD Uniting to scale up TB care in Central Asia 14 and 15 April 2011 Tashkent, Uzbekistan New laboratory diagnostics

More information

Tuberculosis Control. in the South-East Asia Region

Tuberculosis Control. in the South-East Asia Region 2005 Tuberculosis Control in the South-East Asia Region SEA-TB-282 Tuberculosis Control in the South-East Asia Region The Regional Report: 2005 WHO Project No: ICP TUB 001 World Health Organization This

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Short Communication Awareness of Medical Interns Regarding Recent Guidelines of Revised National Tuberculosis Control

More information

Multidrug-Resistant TB

Multidrug-Resistant TB Multidrug-Resistant TB Diagnosis Treatment Linking Diagnosis and Treatment Charles L. Daley, M.D. National Jewish Health University of Colorado Denver Disclosures Chair, Data Monitoring Committee for delamanid

More information

The epidemiology of tuberculosis

The epidemiology of tuberculosis The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications

More information

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases

More information

Sputum grading as a predictor of treatment outcome of new sputum smear positive tuberculosis patients in Khammam Tuberculosis Unit

Sputum grading as a predictor of treatment outcome of new sputum smear positive tuberculosis patients in Khammam Tuberculosis Unit Sputum grading as a predictor of treatment outcome of new sputum smear positive tuberculosis patients in Khammam Tuberculosis Unit Shankar Reddy Dudala 1, Raghotham Reddy K 2, Chandrasekhar Reddy Bolla

More information

Ramesh P. M.*, Saravanan M.

Ramesh P. M.*, Saravanan M. International Journal of Advances in Medicine Ramesh PM et al. Int J Adv Med. 2018 Jun;5(3):561-565 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20181663

More information

TUBERCULOSIS IN THE SAARC REGION AN UPDATE 2006

TUBERCULOSIS IN THE SAARC REGION AN UPDATE 2006 SAARC Tuberculosis and HIV/AIDS Centre TUBERCULOSIS IN THE SAARC REGION AN UPDATE 2006 SAARC Tuberculosis & HIV/AIDS Centre (STC) P. O. Box No. 9517, Kathmandu, Nepal Thimi, Bhaktapur Tel: 6631048, 6632477,

More information

Rajib Saha. 1. Introduction

Rajib Saha. 1. Introduction Tuberculosis Research and Treatment Volume 2016, Article ID 8608602, 8 pages http://dx.doi.org/10.1155/2016/8608602 Research Article Predictors of Treatment Outcome for Retreatment Pulmonary Tuberculosis

More information

TUBERCULOSIS IN THE SAARC REGION AN UPDATE 2005

TUBERCULOSIS IN THE SAARC REGION AN UPDATE 2005 SAARC TB Centre TUBERCULOSIS IN THE SAARC REGION AN UPDATE 2005 SAARC Tuberculosis Centre (STC) (Thimi, Bhaktapur), P. O. Box No. 9517, Kathmandu, Nepal. Tel: 6631048, 6632477, 6632601 Fax: 00977-1-6634379

More information

National Symposium on Universal Health Coverage in India

National Symposium on Universal Health Coverage in India National Symposium on Universal Health Coverage in India Theme: Bridging the Knowledge and Implementation Gap Summary Report Organised by: KIIT School of Public Health (KSPH) Date: 12 th December, 2016

More information

Ram Sharan Gopali (MPH) Executive Director

Ram Sharan Gopali (MPH) Executive Director Ram Sharan Gopali (MPH) Executive Director Basic Facts of Nepal Nepal is a landlocked country located in the WHO Asian region at the edge of the Himalaya between India and the Peoples Republic of China

More information

Costing of the Sierra Leone National Strategic Plan for TB

Costing of the Sierra Leone National Strategic Plan for TB Costing of the Sierra Leone National Strategic Plan for TB 2016-2020 Introduction The Government of Sierra Leone established the National Leprosy Control Programme in 1973 with support from the German

More information

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National

More information

The WHO END-TB Strategy

The WHO END-TB Strategy ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who

More information

CORRELATES OF DELAYED INITIATION OF TREATMENT AFTER CONFIRMED DIAGNOSIS UNDER RNTCP: A CROSS SECTIONAL STUDY IN AHMEDABAD MUNICIPAL CORPORATION, INDIA

CORRELATES OF DELAYED INITIATION OF TREATMENT AFTER CONFIRMED DIAGNOSIS UNDER RNTCP: A CROSS SECTIONAL STUDY IN AHMEDABAD MUNICIPAL CORPORATION, INDIA Original Article CORRELATES OF DELAYED INITIATION OF TREATMENT AFTER CONFIRMED DIAGNOSIS UNDER RNTCP: A CROSS SECTIONAL STUDY IN AHMEDABAD MUNICIPAL CORPORATION, INDIA Financial Support: None declared

More information

TB: A Supplement to GP CLINICS

TB: A Supplement to GP CLINICS TB: A Supplement to GP CLINICS Chapter 4: Improving Access to Affordable and Quality TB Tests in India Authors: Madhukar Pai, MD, PhD Author and Series Editor Tuberculosis Tuberculosis (TB) remains one

More information

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai TB/HIV 2 sides of the same coin Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai Global- Tb new cases Diagnosis-Microscopy ZN,Flourescent microscopy(fm) Rapid, inexpensive test Specificity>95%

More information

Update on Management of

Update on Management of Update on Management of DR TB Definitions Presumptive MDR-TB A patient suspected of drug-resistant TB, based on RNTCP criteria for submission of specimens for drug-susceptibility testing MDR-TB Case A

More information

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection Results of Group Work DOTS expansion and enhancement Objective This group deals with the majority

More information

Managing the Revised National Tuberculosis Control Programme in Your Area. A Training Course. Modules 1 4

Managing the Revised National Tuberculosis Control Programme in Your Area. A Training Course. Modules 1 4 Managing the Revised National Tuberculosis Control Programme in Your Area A Training Course Modules 1 4 1 Course Introduction 2 Ensuring Identification of Tuberculosis Suspects 3 Supporting Laboratory

More information

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India Revised National Tuberculosis Control Programme Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India March 2017 Central TB Division, Directorate General of Health Services, Ministry

More information

Assessing the programmatic management of drug-resistant TB

Assessing the programmatic management of drug-resistant TB Assessing the programmatic management of drug-resistant TB a. Review the programmatic management of drug-resistant TB patients with the TB manager. i. What is the size of MDR-TB problem locally? How many

More information

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms) IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,

More information

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Lancelot M. Pinto, MD, MSc Author Madhukar Pai, MD, PhD co-author and Series Editor Lancelot Pinto is a

More information

TB/HIV Project in the Philippines. Yumiko Yanase

TB/HIV Project in the Philippines. Yumiko Yanase TB/HIV Project in the Philippines Yumiko Yanase 1 TB situation in the Philippines Global rank: 9th Incidence (all): 296 Prevalence (all): 458 TB mortality (all): 49 New MDR-TB: 3.2% Case types notified

More information

Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan

Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan Accra, Ghana May 1 st 2013 Hillary K. Kipruto on behalf of the Kenya team System

More information

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Ministry of Health National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Contents Executive summary... 2 Background... 3 National Tuberculosis Program Overview... 3

More information

SAARC EPIDEMIOLOGICAL RESPONSE ON TUBERCULOSIS

SAARC EPIDEMIOLOGICAL RESPONSE ON TUBERCULOSIS SAARC EPIDEMIOLOGICAL RESPONSE ON TUBERCULOSIS 2017 SAARC Tuberculosis & HIV/AIDS Centre (STAC) i SAARC EPIDEMIOLOGICAL RESPONSE ON TUBERCULOSIS 2017 SAARC Tuberculosis & HIV/AIDS Centre (STAC) Thimi,

More information

SOUTH AFRICA S TB BURDEN - OVERVIEW

SOUTH AFRICA S TB BURDEN - OVERVIEW SOUTH AFRICA S TB BURDEN - OVERVIEW Dr Aaron Motsoaledi, MP: Chairperson of the Board, Stop TB Partnership Minister of Health, South Africa 31 January 2014, Cape Town South Africa s TB Burden Global TB

More information

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE) TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global

More information

A study on non-compliance in tuberculosis cases towards the directly observed treatment short course under RNTCP in Kanpur Nagar

A study on non-compliance in tuberculosis cases towards the directly observed treatment short course under RNTCP in Kanpur Nagar International Journal of Community Medicine and Public Health Srivastava K et al. Int J Community Med Public Health. 2017 Dec;4(12):4485-4489 http://www.ijcmph.com pissn 2394-6032 eissn 2394-6040 Original

More information

Implementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager

Implementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager Implementing revised TB/HIV recording and reporting tools Country Experience Dr Nathan Kapata National TB/ Leprosy Programme Manager Outline Objective Background Implementation of TB/HIV collaborative

More information

NEW STRATEGIES OF TB CONTROL IN INDIA : ARE WE ON THE RIGHT TRACK?

NEW STRATEGIES OF TB CONTROL IN INDIA : ARE WE ON THE RIGHT TRACK? 130 Editorial NEW STRATEGIES OF TB CONTROL IN INDIA : ARE WE ON THE RIGHT TRACK? [Indian J Tuberc 2012; 59: 130-134] The control of tuberculosis still remains elusive as the epidemic of tuberculosis (TB),

More information

TB Data Quality Assurance: United Kingdom

TB Data Quality Assurance: United Kingdom TB Data Quality Assurance: United Kingdom Ibrahim Abubakar, MBBS, PhD, FFPH Tuberculosis Section HPA Centre for Infections 8,655 cases in 2008 14.1 per 100,000 Increase over last 2 decades TB Surveillance

More information

Tuberculosis Control

Tuberculosis Control SEA-TB-293 Tuberculosis Control in the South-East Asia Region The Regional Report: 2006 WHO Project No: ICP TUB 001 Further publications can be obtained from: TB Unit, Department of Communicable Diseases

More information

Authors Malhotra, S; Zodpey, S P; Chandra, S; Vashist, R P; Satyanaryana, S; Zachariah, R; Harries, A D

Authors Malhotra, S; Zodpey, S P; Chandra, S; Vashist, R P; Satyanaryana, S; Zachariah, R; Harries, A D MSF Field Research Should Sputum Smear Examination Be Carried Out at the End of the Intensive Phase and End of Treatment in Sputum Smear Negative Pulmonary TB Patients? Authors Malhotra, S; Zodpey, S P;

More information

Scale up of MDR TB Management in the Philippines: Lessons Learned

Scale up of MDR TB Management in the Philippines: Lessons Learned Scale up of MDR TB Management in the Philippines: Lessons Learned Tropical Disease Foundation in collaboration with the NTP, Department of Health Ma. Imelda D. Quelapio, MD Philippines: Magnitude of the

More information

Issue 9: January March, 2017 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana

Issue 9: January March, 2017 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana Issue 9: January March, 2017 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana Contents Page Editorial and Report Highlights 1 Malaria Burden 2 Key activities undertaken in First

More information

NATIONAL TUBERCULOSIS CONTROL PROGRAMME- SCC AREA Quarterly Report on New and Retreatment Cases of Tuberculosis

NATIONAL TUBERCULOSIS CONTROL PROGRAMME- SCC AREA Quarterly Report on New and Retreatment Cases of Tuberculosis NATIONAL TUBERCULOSIS CONTROL PROGRAMME- SCC AREA Quarterly Report on New and Retreatment Cases of Tuberculosis Patients registered during quarter* of 20 Name of area No.# Name of the Reporter Signature:

More information

TB Control activities and Success factors and Challenges for monitoring and Evaluation of the Mangement of LTBI in Cambodia

TB Control activities and Success factors and Challenges for monitoring and Evaluation of the Mangement of LTBI in Cambodia TB Control activities and Success factors and Challenges for monitoring and Evaluation of the Mangement of LTBI in Cambodia Global Consultation on Programmatic Management of LTBI 27-28 /04/ 2016 Seoul,

More information

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers

ANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers ANALYSIS AND USE OF HEALTH FACILITY DATA Guidance for tuberculosis programme managers WORKING DOCUMENT SEPTEMBER 2018 World Health Organization 2018 All rights reserved. This is a working document and

More information

Open Access Article pissn eissn

Open Access Article   pissn eissn Original article ASSESSMENT OF LONG-TERM OUTCOME AMONG NEW SMEAR POSITIVE PULMONARY TB PATIENTS TREATED WITH INTERMITTENT REGIMEN UNDER RNTCP A RETROSPECTIVE COHORT STUDY Paresh Dave 1, Kiran Rade 2, Bhavesh

More information

Finding the missing TB cases

Finding the missing TB cases Finding the missing TB cases Optimizing strategies to enhance case detection in high HIV burden settings Dr Malgosia Grzemska Global TB Programme, WHO/HQ, Geneva SWITZERLAND Child and Adolescent TB Working

More information

10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan,

10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan, 10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan, 2006 2015 Introduction A significant scaling-up of advocacy, communication and social mobilization for TB will

More information

Tuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012

Tuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012 Tuberculosis New TB diagnostics. New drugs.new vaccines Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012 Tuberculosis (TB )is a bacterial disease caused by Mycobacterium tuberculosis (occasionally

More information

TB Control in Finland - the role of THL

TB Control in Finland - the role of THL TB Control in Finland - the role of THL Hanna Soini THL, Department of Health Security 1 TB in Finland 1950-2014 12000 10000 8000 6000 TB ulkomaalaiset TB yhteensä 4000 2000 0 1950 1955 1960 1965 1970

More information

REGIONAL COMMITTEE FOR AFRICA AFR/RC53/13 Rev June 2003 Fifty-third session Johannesburg, South Africa, 1 5 September 2003

REGIONAL COMMITTEE FOR AFRICA AFR/RC53/13 Rev June 2003 Fifty-third session Johannesburg, South Africa, 1 5 September 2003 WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR AFRICA ORGANISATION MONDIALE DE LA SANTE BUREAU REGIONAL DE L AFRIQUE ORGANIZAÇÃO MUNDIAL DE SAÚDE ESCRITÓRIO REGIONAL AFRICANO REGIONAL COMMITTEE FOR AFRICA

More information